Are We Too Afraid of Our Instruments? - Summary - MDSpire

Are We Too Afraid of Our Instruments?

An obsession with spotless systems means we risk working for our instruments, rather than the other way around

  • By

  • Jennifer Field

  • June 29, 2026

  • 4 min

Share

Objective:

To encourage analytical scientists to deeply understand their instruments and explore creative methodologies in their research.

Approach:
  • Understanding Instruments: Emphasizes the importance of knowing instruments intimately to enhance their use in research.
  • Innovative Techniques: Discusses unconventional methods like large-volume injection and in situ experiments to improve workflow and sensitivity.
  • Critical Evaluation of Cleanup Steps: Critiques the habitual use of solid-phase extraction and advocates for simpler alternatives when appropriate.
Key Findings:
  • In-depth knowledge of instruments can lead to innovative research approaches, as demonstrated in PFAS research.
  • Simplifying workflows, such as through large-volume injection, can improve efficiency and reduce costs.
  • Understanding when cleanup steps are necessary is crucial to avoid unnecessary complexity and waste.
Interpretation:

Encourages a balance between maintaining instrument cleanliness and exploring creative methodologies in research.

Limitations:
  • The article does not provide empirical data to support claims about the effectiveness of alternative methods.
  • The insights may not apply universally to all laboratory settings or types of analyses.
Conclusion:

A deep understanding and creative use of instruments can enhance research outcomes, while unnecessary cleanup steps should be minimized.

Original Source(s)

Are We Too Afraid of Our Instruments?

  • by Jennifer Field

  • June 29, 2026

Related Content

Autonomic nervous system: an integrative regulator in circadian rhythm of blood pressure

Pregnancy Health Score Tied to Later Cardiometabolic Risk

A modified cardiovascular health score during pregnancy was associated with later diagnosis of chronic hypertensive and metabolic conditions.

What the Iran War Means for Pharma Supply Chains

Argon & Co’s Michel Savini discusses the medicines most exposed to geopolitical instability, and why scenario planning remains underused across life sciences

  • June 29, 2026

  • 8 min